Access to a PrEP HIV prevention clinic in Toronto has become an important part of primary care for individuals who may benefit from additional HIV risk reduction strategies. Pre-exposure prophylaxis (PrEP) is a clinically established approach supported by Health Canada and recommended in national guidelines. At Cloud Care Clinics in Toronto, Ontario, our team provides confidential, evidence-based PrEP consultations within a respectful and professional primary care setting.
What Is PrEP?
PrEP, or pre-exposure prophylaxis, refers to the use of antiretroviral medication by HIV-negative individuals to reduce the likelihood of acquiring HIV infection. When taken as prescribed, PrEP has been shown in clinical trials to significantly reduce the risk of HIV transmission through sexual contact and injection drug use.
Health Canada has approved two formulations of PrEP for use in Canada:
- Oral daily PrEP — most commonly emtricitabine/tenofovir disoproxil fumarate (sold under brand names including Truvada and in generic forms), taken once daily as a tablet
- Injectable PrEP — long-acting cabotegravir (Apretude), administered by a healthcare provider as an intramuscular injection every two months after an initiation period
PrEP is not a treatment for HIV and does not treat any other sexually transmitted infection. It is one component of a comprehensive approach to sexual health, used alongside regular HIV and STI testing, condom use, and ongoing clinical monitoring. The Canadian Task Force on Preventive Health Care (CTFPHC) has issued guidance supporting the use of PrEP as a preventive health intervention for individuals at substantial risk of HIV acquisition.
Who May Benefit from PrEP?
PrEP is intended for HIV-negative adults who may be at elevated risk of HIV exposure. A healthcare provider will assess individual circumstances during a clinical consultation to determine whether PrEP may be appropriate. Factors that are commonly considered include:
- Sexual activity with partners whose HIV status is unknown or who are HIV-positive without confirmed viral suppression
- Inconsistent condom use during anal or vaginal intercourse with multiple partners
- A recent diagnosis of a bacterial sexually transmitted infection (STI), such as syphilis, gonorrhea, or chlamydia
- Current or recent use of injection drugs, particularly in circumstances involving shared equipment
- Personal preference to use an additional HIV prevention method alongside other strategies
PrEP is not appropriate for individuals who are HIV-positive, those with specific kidney function concerns that may be contraindicated with certain formulations, or those for whom the medication may interact adversely with other prescriptions. A complete clinical assessment is always required before a prescription is issued.
How to Access PrEP in Ontario
In Ontario, PrEP requires a prescription from a licensed healthcare provider, such as a physician or nurse practitioner. Eligible patients may access coverage through several provincial programs:
- Ontario Drug Benefit (ODB) Program — Individuals who receive social assistance, are 65 or older, reside in a long-term care facility, or are enrolled in specific government programs may be eligible for ODB coverage of PrEP medications.
- OHIP+ — Ontario residents under the age of 25 without private drug insurance may receive coverage for many prescription medications, including generic PrEP formulations, at no cost through the OHIP+ program.
- Trillium Drug Benefit (TDB) — For individuals with high prescription drug costs relative to their household income, the Trillium Drug Benefit may provide partial or full coverage after a deductible.
- Private insurance — Many employer-sponsored benefit plans include drug coverage that may apply to PrEP. A pharmacist or benefit plan administrator can confirm coverage details.
- Manufacturer assistance programs — Patient support programs from pharmaceutical manufacturers may offer assistance for individuals who face gaps in coverage.
The Ontario College of Pharmacists (OCP) and the National Association of Pharmacy Regulatory Authorities (NAPRA) have established standards for the dispensing and counselling of medications including antiretrovirals. Your pharmacist is a valuable resource for information about your specific medication, storage, and adherence.
What to Expect During a PrEP Consultation
A PrEP consultation at a Toronto clinic is a clinical appointment focused on assessing your eligibility, providing information, and ordering appropriate baseline tests. At Cloud Care Clinics, your consultation is confidential and conducted in a non-judgmental environment.
During your initial appointment, your provider will typically:
- Review your medical and sexual health history in a confidential clinical context
- Confirm a current negative HIV status through rapid or laboratory-based HIV testing
- Order baseline bloodwork, including kidney function (creatinine and eGFR), hepatitis B serology, and hepatitis C antibody testing
- Conduct or arrange comprehensive STI screening
- Discuss which PrEP formulation may be appropriate based on your health profile and preferences
- Review how to take the medication, what to do if a dose is missed, and when protection is considered established
- Address questions about interactions with other medications
- Outline the follow-up schedule required to continue receiving a PrEP prescription
Your provider will not issue a prescription without first confirming a negative HIV status and completing the appropriate clinical assessment. This process reflects both best practice and the expectations of the College of Physicians and Surgeons of Ontario (CPSO) for responsible prescribing.
Monitoring and Follow-Up
Ongoing monitoring is a mandatory component of PrEP use. Clinical guidelines recommend follow-up appointments approximately every three months for individuals on daily oral PrEP, and prior to each injection for those on long-acting cabotegravir. These appointments serve several important clinical purposes:
- HIV testing — Repeated HIV testing at each follow-up visit confirms continued HIV-negative status and ensures PrEP remains appropriate. If HIV infection is detected, antiretroviral therapy must be initiated promptly, as continuing PrEP alone in an HIV-positive individual may contribute to drug resistance.
- Kidney function monitoring — Tenofovir-based oral PrEP medications require periodic kidney function assessment, particularly creatinine and eGFR, to detect any changes that may affect continued eligibility.
- STI screening — Routine testing for bacterial STIs, including gonorrhea, chlamydia, and syphilis, is recommended at each follow-up visit, consistent with provincial sexual health guidelines.
- Adherence support — Regular clinical contact provides an opportunity to discuss any challenges with medication adherence, side effects, or changes in circumstances that may affect risk level or medication appropriateness.
Prescriptions for PrEP are typically issued for 90-day periods, aligned with the follow-up schedule. Continuation of the prescription depends on maintaining regular clinical appointments and meeting eligibility criteria at each visit.
PrEP Services at Cloud Care Clinics
Cloud Care Clinics offers PrEP consultations and ongoing PrEP management as part of its sexual health services in Toronto, Ontario. Our clinical team is committed to providing evidence-informed care in a confidential and inclusive environment, in accordance with CPSO standards and PHIPA privacy legislation.
Our PrEP services include:
- Initial PrEP eligibility assessment and consultation
- HIV and STI testing at initiation and follow-up
- Baseline and ongoing bloodwork requisitions
- Prescription and renewal of oral daily PrEP medications
- Referral to specialist services when clinically indicated
- Assistance navigating Ontario drug coverage programs
Appointments at Cloud Care Clinics are available for new and existing patients. If you are considering PrEP for the first time or are looking to continue PrEP care with a Toronto provider, our team can support your needs. Visit our services page to learn more about all available health services at our clinic.
Frequently Asked Questions
Is PrEP the same as treatment for HIV?
No. PrEP is a preventive medication taken by HIV-negative individuals to reduce the risk of acquiring HIV. It is not a treatment for HIV infection. Individuals who are already HIV-positive require antiretroviral therapy (ART) prescribed and managed by a physician experienced in HIV care. A current negative HIV test is required before any healthcare provider can prescribe PrEP.
How long does it take for oral PrEP to become effective?
Clinical evidence indicates that daily oral PrEP reaches protective drug levels in rectal tissue within approximately seven days of consistent daily use, and in vaginal tissue within approximately twenty-one days. Long-acting injectable cabotegravir is administered by a healthcare provider and follows a specific initiation schedule. Your provider will explain the timing relevant to your chosen formulation and personal circumstances.
Will my PrEP use be covered by OHIP or another Ontario program?
The clinical consultation with a physician or nurse practitioner is covered by OHIP for eligible Ontario residents. Coverage for the PrEP medication itself depends on your age, income, existing drug benefits, and the specific drug program for which you qualify. Programs such as OHIP+, the Ontario Drug Benefit, the Trillium Drug Benefit, and private insurance plans may cover part or all of the medication cost. Your provider and pharmacist can help you determine what coverage may be available to you.
Can I stop taking PrEP if my circumstances change?
Yes. PrEP is not a lifelong commitment. If your risk circumstances change, or if you choose to stop for any reason, you should speak with your healthcare provider before discontinuing. For oral PrEP, clinical guidance typically recommends continuing the medication for a period after the last potential exposure. Your provider will give you specific guidance based on your situation and the formulation you are using.
Does using PrEP mean I no longer need to use condoms or get tested for STIs?
PrEP reduces the risk of HIV acquisition but does not protect against other sexually transmitted infections such as gonorrhea, chlamydia, syphilis, or herpes. Condoms remain effective at reducing transmission of these infections, and regular STI testing is a recommended part of comprehensive sexual health care for sexually active individuals. PrEP is most effective as one part of a broader sexual health strategy, discussed with your healthcare provider based on your individual circumstances.
Ready to take the next step? Book an appointment at Cloud Care Clinics in Toronto today.
This article is for informational purposes only and does not constitute medical advice. Please consult your healthcare provider for personalized guidance. Information in this article may become outdated over time. For the most current clinical guidelines and recommendations, please refer to your healthcare provider or the relevant regulatory body.
